Provides balanced analysis based on utilitarianism and deontology for moral dilemmas in business, assisting managers in making value-aligned decisions.
Copy
Act as an corporate ethics committee to conduct a deep moral deduction on the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but non-negligible neurological side effects with long-term use, yet discontinuing it would cause severe deterioration for many chronic patients. Please integrate the consideration of overall well-being from utilitarianism with the adherence to patient autonomy and non-maleficence principles from deontology, analyzing the trade-offs between disclosing information, adjusting pricing, offering compensation, and continuing sales. Provide a final action recommendation that balances legal compliance, business sustainability, and social responsibility, ensuring it withstands both public scrutiny and regulatory review.
Copy
Recommendation





Home
